Inhibitori topoizomeraze (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Inhibitori topoizomeraze" in Serbian language version.

refsWebsite

Global rank Serbian rank

2^nd place

4^th place

4^th place

8^th place

1web.archive.org

1^st place

1^st place

1,684^th place

703^rd place

1mercksource.com

8,363^rd place

1,360^th place

1landesbioscience.com

low place

low place

1,293^rd place

802^nd place

4,455^th place

2,178^th place

cancer.gov

„Definition of topoisomerase inhibitor - NCI Dictionary of Cancer Terms”. Архивирано из оригинала 10. 05. 2009. г.

doi.org

Mitscher LA (2005). „Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents”. Chem. Rev. 105 (2): 559—92. PMID 15700957. doi:10.1021/cr030101q.
Fisher LM, Pan XS (2008). „Methods to assay inhibitors of DNA gyrase and topoisomerase IV activities”. Methods Mol. Med. 142: 11—23. PMID 18437302. doi:10.1007/978-1-59745-246-5_2.
Scott Classen; Stephane Olland & James M. Berger (2003). „Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187”. PNAS. 100 (19): 10629—10634. doi:10.1073/pnas.1832879100.
Cheryl L. Baird; Matthew S. Gordon; David M. Andrenyak; James F. Marecek; Janet E. Lindsley (2001). „The ATPase Reaction Cycle of Yeast DNA Topoisomerase II”. The Journal of Biological Chemistry. 276: 27893—27898. doi:10.1074/jbc.M102544200.

jbc.org

Cheryl L. Baird; Matthew S. Gordon; David M. Andrenyak; James F. Marecek; Janet E. Lindsley (2001). „The ATPase Reaction Cycle of Yeast DNA Topoisomerase II”. The Journal of Biological Chemistry. 276: 27893—27898. doi:10.1074/jbc.M102544200.

landesbioscience.com

Robinson HM, Bratlie-Thoresen S, Brown R, Gillespie DA (2007). „Chk1 is required for G2/M checkpoint response induced by the catalytic topoisomerase II inhibitor ICRF-193”. Cell Cycle. 6 (10): 1265—7. PMID 17495539.

mercksource.com

„Dorlands Medical Dictionary:topoisomerase inhibitor”. ^{[мртва веза]}

nih.gov

ncbi.nlm.nih.gov

Mitscher LA (2005). „Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents”. Chem. Rev. 105 (2): 559—92. PMID 15700957. doi:10.1021/cr030101q.
Fisher LM, Pan XS (2008). „Methods to assay inhibitors of DNA gyrase and topoisomerase IV activities”. Methods Mol. Med. 142: 11—23. PMID 18437302. doi:10.1007/978-1-59745-246-5_2.
Robinson HM, Bratlie-Thoresen S, Brown R, Gillespie DA (2007). „Chk1 is required for G2/M checkpoint response induced by the catalytic topoisomerase II inhibitor ICRF-193”. Cell Cycle. 6 (10): 1265—7. PMID 17495539.

pnas.org

Scott Classen; Stephane Olland & James M. Berger (2003). „Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187”. PNAS. 100 (19): 10629—10634. doi:10.1073/pnas.1832879100.

web.archive.org

„Definition of topoisomerase inhibitor - NCI Dictionary of Cancer Terms”. Архивирано из оригинала 10. 05. 2009. г.